OXEIA BIOPHARMACEUTICALS NAMED MOST INNOVATIVE mTBI COMPANY 2026
Second Year Running Oxeia is Recognized for its Concussion Drug, OXE103; Award Honors Excellence, Resilience and Innovation BOSTON, MA, UNITED STATES, May 15, 2026 /EINPresswire.com/ -- Global Health & Pharma announced today that Oxeia …